摘要：

The invention relates to pharmaceutical compositions and methods for treating and/or preventing -associated disorders, particularly disorders of the gastrointestinal tract. The pharmaceutical compositions comprise as active ingredient a therapeutically effective amount of a compound which inhibits the growth-enhancing effect of gastrin on . The active ingredient may specifically be a compound which is capable of inhibiting gastrin uptake by , and/or which is an antagonist of the human or gastrin receptor.

展开